Loss of the triglyceride synthesizing enzyme DGAT1 alters cholesterol metabolism.
Reduced cholesterol absorption by intestine-specific DGAT1 deficiency
Increased neutral sterol loss upon DGAT1 deficiency/inhibition
Smaller post-prandial chylomicrons circulate less cholesterol.
DGAT1 inhibition leads to increased trans-intestinal cholesterol excretion.